Pharmaceuticals by P/E ratio

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Edgewise Therapeutics has the lowest figure of the 33 pharmaceuticals ranked by P/E ratio, at 4.9, followed by Alnylam Pharmaceuticals (7.7) and Novo Nordisk (10.0). Figures as of 18 Nov 2026, 15:42 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
33
Lowest
Edgewise Therapeutics4.9
Median
40.2
Combined market value
SAR 19.06T
Countries
10
Not ranked
28no P/E ratio on file

Market values as of .

Pharmaceuticals by P/E ratio
#CompanyP/E ↑Market capPriceToday1 yearPrice, 30 daysCountry
1Edgewise TherapeuticsEWTX · Health Care4.9SAR 16.7BSAR 152.76 3.13% down 88% up United States
2Alnylam PharmaceuticalsALNY · Health Care7.7SAR 76.9BSAR 574.03 2.21% down 66% down United States
3Novo NordiskNVO · Health Care10.0SAR 652.9BSAR 148.15 2.96% down 17% down Denmark
4GrifolsGRFS · Health Care10.3SAR 21.7BSAR 31.92 1.39% down 1% up Spain
5Bristol-Myers SquibbBMY · Health Care13.3SAR 458.7BSAR 224.42 2.48% down 34% up United States
6ZoetisZTS · Health Care14.2SAR 127.5BSAR 313.85 0.23% up 29% down United States
7GSKGSK · Health Care17.0SAR 367.2BSAR 183.20 0.81% down 6% up United Kingdom
8Ascendis PharmaASND · Health Care17.8SAR 66.4BSAR 1,012.88 0.43% down 28% up Denmark
9Regeneron PharmaceuticalsREGN · Health Care21.1SAR 370.5BSAR 3,581.94 0.30% down 36% up United States
10United TherapeuticsUTHR · Health Care21.5SAR 91.1BSAR 2,138.16 2.41% down 23% up United States
11SanofiSNY · Health Care23.5SAR 425.9BSAR 177.38 0.50% down 4% down France
12AstraZenecaAZN · Health Care25.3SAR 1.04TSAR 670.83 1.88% down 2% up United Kingdom
13Protagonist TherapeuticsPTGX · Health Care26.3SAR 30.5BSAR 466.96 0.14% down 46% up United States
14NovartisNVS · Health Care29.8SAR 1.11TSAR 586.58 1.73% down 25% up Switzerland
15Vertex PharmaceuticalsVRTX · Health Care34.3SAR 507BSAR 1,999.66 0.21% down 27% up United States
16Abbott LaboratoriesABT · Health Care38.9SAR 676.8BSAR 390.78 0.51% down 17% down United States
17PfizerPFE · Health Care40.2SAR 601.7BSAR 105.57 1.14% down 14% up United States
18Dr. Reddy's LaboratoriesRDY · Health Care41.5SAR 46.7BSAR 56.06 1.05% up 5% up India
19Johnson & JohnsonJNJ · Health Care41.7SAR 2.48TSAR 1,031.56 1.32% down 38% up United States
20GenmabGMAB · Health Care43.8SAR 118.6BSAR 192.28 1.35% down 70% up Denmark
21Royalty PharmaRPRX · Health Care44.7SAR 147.4BSAR 256.34 0.50% down 78% up United States
22Eli LillyLLY · Health Care45.2SAR 4.65TSAR 5,224.58 1.60% down 35% up United States
23AbbVieABBV · Health Care49.4SAR 1.91TSAR 1,078.07 1.85% down 26% up United States
24Corcept TherapeuticsCORT · Health Care50.7SAR 27.7BSAR 252.83 3.81% down 8% down United States
25BeOne MedicinesONC · Health Care51.7SAR 172.9BSAR 1,513.55 2.36% down 17% up Switzerland
26Amneal PharmaceuticalsAMRX · Health Care53.6SAR 28BSAR 80.46 1.56% up 83% up United States
27Jazz PharmaceuticalsJAZZ · Health Care71.8SAR 58.4BSAR 910.22 0.81% up 37% up Ireland
28Kiniksa Pharmaceuticals InternationalKNSA · Health Care72.3SAR 28.1BSAR 358.22 0.41% up 126% up United Kingdom
29TG TherapeuticsTGTX · Health Care94.4SAR 35.9BSAR 237.33 0.89% up 107% up United States
30Teva Pharmaceutical IndustriesTEVA · Health Care98.3SAR 185BSAR 158.52 0.84% down 74% up Israel
31Ligand PharmaceuticalsLGND · Health Care118SAR 22.1BSAR 1,105.49 0.31% up 43% up United States
32Merck & CoMRK · Health Care141SAR 1.29TSAR 524.05 2.55% down 51% up United States
33Takeda PharmaceuticalTAK · Health Care305SAR 256.2BSAR 80.18 1.22% down 54% up Japan

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR). 28 companies have no P/E ratio on file and are not ranked here.

Questions and answers

Which pharmaceuticals have the lowest P/E ratio?

Edgewise Therapeutics (4.9), Alnylam Pharmaceuticals (7.7) and Novo Nordisk (10.0) have the lowest P/E ratio of the 33 pharmaceuticals ranked here as of 18 Nov 2026, 15:42 UTC.

How many pharmaceuticals are in this ranking?

33 are ranked by P/E ratio. 28 more have no P/E ratio on file and are left out rather than ranked at zero.

What are these pharmaceuticals worth together?

The 33 pharmaceuticals ranked by P/E ratio have a combined market value of SAR 19.06T as of 18 Nov 2026, 15:42 UTC.

What does ranking by P/E ratio measure?

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Cite this page

Funkfolio, “Pharmaceuticals by P/E ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=pe-ratio

Underlying data: Yahoo Finance; SEC EDGAR.